Original articlesEfficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy:a dose-ranging clinical study
Under an Elsevier user license
open archive
Keywords
chemotherapy
dose-ranging
emesis
5-hydroxytryptamine type 3 receptor antagonist
nausea
palonosetron
Cited by (0)
Copyright © 2004 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.